Norristown, PA, United States of America

Dinubhai H Shah


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Norristown, PA (US) (1982 - 1991)
  • Blue Bell, PA (US) (1997)

Company Filing History:


Years Active: 1982-1997

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Dinubhai H Shah: Innovator in Alpha-Adrenergic Antagonism

Introduction

Dinubhai H Shah is a notable inventor based in Norristown, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of alpha-adrenergic receptor antagonists. With a total of four patents to his name, Shah's work has had a considerable impact on medical treatments.

Latest Patents

Shah's latest patents include innovative compounds such as Furo- and thieno[4,3,2-ef][3]benzazepines, which are useful as alpha-adrenergic receptor antagonists. These compounds are designed to produce alpha-adrenergic antagonism, and the pharmaceutical compositions derived from them are aimed at improving treatment methods. The specific formulas and variables are detailed in the patent specifications, showcasing the complexity and potential of his inventions.

Career Highlights

Throughout his career, Dinubhai H Shah has worked with prominent companies, including SmithKline Beecham Corporation and SmithKline Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in the field.

Collaborations

Shah has collaborated with notable colleagues such as Robert M DeMarinis and John J Lafferty. These partnerships have likely enriched his research and development efforts, leading to the successful creation of his patented inventions.

Conclusion

Dinubhai H Shah's contributions to the field of pharmaceuticals, particularly in the area of alpha-adrenergic antagonism, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical treatments and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…